10q10k10q10k.net
Hims & Hers Health, Inc.

Hims & Hers Health, Inc.HIMSEarnings & Financial Report

NYSE · telehealth

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

NextMar 13, 2026

HIMS Q3 2025 Key Financial Metrics

Revenue

$599.0M

Gross Profit

$442.1M

Operating Profit

$11.8M

Net Profit

$15.8M

Gross Margin

73.8%

Operating Margin

2.0%

Net Margin

2.6%

YoY Growth

49.2%

EPS

$0.06

Financial Flow

Hims & Hers Health, Inc. Q3 2025 Financial Summary

Hims & Hers Health, Inc. reported revenue of $599.0M for Q3 2025, with a net profit of $15.8M (2.6% margin). Cost of goods sold was $156.9M, operating expenses totaled $430.3M.

Key Financial Metrics

Total Revenue$599.0M
Net Profit$15.8M
Gross Margin73.8%
Operating Margin2.0%
Report PeriodQ3 2025

Hims & Hers Health, Inc. Annual Revenue by Year

Hims & Hers Health, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $1.5B).

YearAnnual Revenue
2024$1.5B
2023$872.0M
2022$526.9M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$246.6M$278.2M$315.6M$401.6M$481.1M$586.0M$544.8M$599.0M
YoY Growth47.5%45.8%51.8%77.1%95.1%110.7%72.6%49.2%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$441.2M$448.1M$480.5M$602.3M$707.5M$891.7M$1.88B$2.23B
Liabilities$97.2M$103.6M$118.5M$162.2M$230.8M$342.4M$1.31B$1.65B
Equity$344.0M$344.5M$362.0M$440.1M$476.7M$549.3M$562.7M$581.0M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$22.0M$25.8M$53.6M$85.3M$86.4M$109.1M$-19.1M$148.7M